Promising anti-diabetic effect of dextran sulfate sodium: Is it its clinical come back?
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Ireland Ltd
Abstract
Clinical studies showed that dextran sulfate sodium (DSS) alleviates stroke, diabetic retinopathy and hypercholesterolemia, yet its mechanism of action was unrevealed. This study show that DSS reduces hyperglycemia, plasma insulin and enhances glucose utilization by attenuating ROS production, suggesting a novel therapeutic use of DSS in diabetes and its complication. © 2019 Elsevier B.V.
Description
Keywords
Diabetes, Diabetes complications, Hypoglycemic agents, Animals, Dextran sulfate, Diabetes mellitus, Humans, Male, Mice, Glucose, Insulin, Reactive oxygen metabolite, Superoxide, Antidiabetic agent, Animal experiment, Animal model, Animal tissue, Antidiabetic activity, Article, Controlled study, Drug mechanism, Glucose blood level, Glucose utilization, Hyperglycemia, Insulin blood level, Mouse, Non insulin dependent diabetes mellitus, Nonhuman, Oral glucose tolerance test, Pancreas tissue, Animal, Human